These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Author: Prandota J.
    Journal: Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331.
    Abstract:
    Single doses of 2 mg/kg of furosemide (F) were given postprandially as tablets to 17 steroid-responsive nephrotic syndrome (NS) patients, 2.5-15 years old, and seven control children requiring F therapy. One-half, 1, and 2 h after administration, F absorption rate, calculated from the drug urinary excretion data, was significantly more rapid in the NS patients compared to that in the controls. Bioavailability of F in the nephrotic children averaged 58.8% indicating that the gastrointestinal absorption of the drug was unaffected by the disease and by the age of the patients. The first pass effect of F was 24% of the administered dose. The elimination half-life of F, calculated from the drug urinary excretion data in the NS patients was 2.06 +/- 0.96 h (mean +/- SD), whereas in the control children, it was 2.14 +/- 0.69 h. There seems to be no relationship between F elimination half-life and the serum albumin concentration in the NS patients. Also, no correlation was found between the amount of F (mg) excreted in urine during 2 or 6 h after administration (the time of complete absorption of F from the gastrointestinal tract, and the time of the drug diuretic effect, respectively) and the serum albumin concentration in the NS patients. Moreover, no significant difference in the cumulative F urinary excretion was found between both groups of children. The data indicate that factors in addition to serum albumin concentration play a role in the elimination kinetics of F in nephrotic children.
    [Abstract] [Full Text] [Related] [New Search]